Stay updated on Roxadustat Efficiency & Safety in Anemia of Lower Risk MDS Clinical Trial
Sign up to get notified when there's something new on the Roxadustat Efficiency & Safety in Anemia of Lower Risk MDS Clinical Trial page.

Latest updates to the Roxadustat Efficiency & Safety in Anemia of Lower Risk MDS Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe page has undergone significant content removal, particularly regarding the details of a study on FG-4592 for treating anemia in patients with lower risk MDS, including key inclusion and exclusion criteria. The revision number has been updated from v2.14.4 to v2.15.0.SummaryDifference10%
- Check30 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check37 days agoChange DetectedThe web page has been updated to version 2.14.3, replacing the previous version 2.14.2.SummaryDifference0.1%
- Check66 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.SummaryDifference0.9%
- Check87 days agoChange DetectedThe page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference0.9%
Stay in the know with updates to Roxadustat Efficiency & Safety in Anemia of Lower Risk MDS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Roxadustat Efficiency & Safety in Anemia of Lower Risk MDS Clinical Trial page.